Siemens Enters Genomic Market in Partnership to Develop Novel Diagnostic | GenomeWeb

NEW YORK, Nov. 2 – Siemens, the German electronics giant, and biotechnology company and countrymate november have announced plans to co-develop a novel DNA-based electrochemical diagnostic system and marking Siemens’ debut into genomics.

Terms of the agreement, originally announced in September, call for november to develop the biochemical and electrochemical methods while Medical Solutions, a Siemens business unit, will be responsible for the device itself. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.